Simultaneous inhibition of B7 and LFA-1 signaling prevents rejection of discordant neural xenografts in mice lacking CD40L

Xenotransplantation

Volumn 9, Issue 1, 2002, Pages 68-76

  Larsson, Lena C ^a   Corbascio, Matthias ^b   Widner, Håkan ^a   Pearson, Thomas C ^c   Larsen, Christian P ^c   Ekberg, Henrik ^b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD40 ligand; CTLA4Ig; Embryonic; LFA 1; Neural tissue grafts; Parkinson's disease; Porcine

Indexed keywords

B7 ANTIGEN; CD40 LIGAND; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DOPAMINE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1 ANTIBODY; UNCLASSIFIED DRUG;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; DISCORDANT NEURAL XENOGRAFT; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; EMBRYO; EMBRYONAL TISSUE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOMODULATION; LYMPHOCYTIC INFILTRATION; MESENCEPHALON; MICROGLIA; MOUSE; NERVOUS TISSUE; NEUROTRANSMISSION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SWINE; T LYMPHOCYTE ACTIVATION; TISSUE GRAFT; XENOGRAFT;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD4; ANTIGENS, CD8; ANTIGENS, CD80; ANTIGENS, CD86; BRAIN TISSUE TRANSPLANTATION; CD40 LIGAND; GRAFT REJECTION; HUMANS; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, ANIMAL; SIGNAL TRANSDUCTION; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0036461399     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3089.2002.1o010.x     Document Type: Article

References (33)

1. SCHAPIRA AHV. Parkinson's disease. BMJ 1999; 318: 311.
2. DUNNETT SB, BJÖRKLUND A. Prospects for new restorative and neuroprotective treatments in Parkinson's disease. Nature 1999; 399: A32.
3. LANGSTON JW, FORNO LS, TETRUD J et al. Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1, 2,3, 6-tetrahydropyridine exposure. Ann Neurol 1999; 46: 598.
4. BJÖRKLUND A, LINDVALL O. Cell replacement therapies for central nervous system disorders. Nat Neurosci 2000; 3: 537.
5. WIDNER H, TETRUD J, REHNCRONA S et al. Bilateral fetal mesencephalic grafting in two patients with severe parkinsonism induced by 1-methyl-4-phenyl-1, 2,3, 6-tetrahydropyridine (MPTP). N Engl J Med 1992; 327: 1556.
6. KORDOWER JH, FREEMAN TB, SNOW BJ et al. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med 1995; 332: 1118.
7. PICCINI P, BROOKS DJ, BJORKLUND A et al. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat Neurosci 1999; 2: 1137.
8. GAGE FH. Mammalian neural stem cells. Science 2000; 287: 1433.
9. PAKZABAN P, ISACSON O. Neural xenotransplantation: reconstruction of neuronal circuitry across species barriers. Neuroscience 1994; 62: 989.
10. SCHUMACHER JM, ELLIAS SA, PALMER EP et al. Transplantation of embryonic porcine mesencephalic tissue in patients with PD. Neurology 2000; 54: 1042.
11. DINSMORE JH, MANHART C, RAINERI R, JACOBY DB, MOORE A. No evidence for infection of human cells with porcine endogenous retrovirus (PERV) after exposure to porcine fetal neuronal cells. Transplantation 2000; 70: 1382.
12. DEACON T, SCHUMACHER J, DINSMORE J et al. Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nat Med 1997;3:350.
13. WIDNER H, BRUNDIN P. Immunological aspects of grafting in the mammalian central nervous system. A review and speculative synthesis. Brain Res Rev 1988; 13: 287.
14. GALPERN WR, BURNS LH, DEACON TW, DINSMORE J, ISACSON O. Xenotransplantation of porcine ventral mesencephalon in a rat model of Parkinson's disease: functional recovery and graft morphology. Exp Neurol 1996; 140: 1.
15. LARSSON LC, CZECH KA, BRUNDIN P, WIDNER H. Intrastriatal ventral mesencephalic xenografts of porcine tissue in rats: immune response and functional effects. Cell Transplant 2000; 9: 261.
16. BREVIG T, HOLGERSSON J, WIDNER H. Xenotransplantation for CNS repair: immunological barriers and strategies to overcome them. Trends Neurosci 2000; 23: 337.
17. LARSSON LC, CZECH KA, WIDNER H, KORSGREN O. Discordant neural tissue xenografts survive longer in immunoglobulin deficient mice. Transplantation 1999; 68: 1153.
18. LARSSON LC, ANDERSON P, WIDNER H, KORSGREN O. Enhanced survival of porcine neural xenografts in mice lacking CD1d1; but no effect of NK1.1 depletion. Cell Transplantation 2001 (in press).
19. WENNBERG L, CZECH KA, LARSSON LC, MIRZA B, BENNETT W, SONG Z, WIDNER H. Effects of immunosuppressive treatment on host responses against intracerebral porcine neural tissue xenografts in rats. Transplantation 2001 (in press).
20. SCHWARTZ RH. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 1992; 71: 1065.
21. GREWAL IS, FLAVELL RA. CD40 and CD154 in cell-mediated immunity. Ann Rev Immunol 1998; 16: 111.
22. TAN J, TOWN T, PARIS D et al. Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation. Science 1999; 286: 2352.
23. TRAMBLEY J, BINGAMAN AW, LIN A et al. Asialo GM1 (+) CD8 (+) T cells play a critical role in costimulation blockade-resistant allograft rejection. J Clin Invest 1999; 104: 1715.
24. BREVIG T, KRISTENSEN T, ZIMMER J. Expression of major histocompatibility complex antigens and induction of human T lymphocyte proliferation by astrocytes and macrophages from porcine fetal brain. Exp Neurol 1999; 159: 474.
25. DEETHS MJ, MESCHER MF. ICAM-1 and B7-1 provide similar but distinct costimulation for CD8+ T cells, while CD4+ T cells are poorly costimulated by ICAM-1. Eur J Immunol 1999; 29: 45.
26. NICOLLS MR, COULOMBE M, YANG H, BOLWERK A, GILL RG. Anti-LFA-1 therapy induces long-term islet allograft acceptance in the absence of IFN-gamma or IL-4. J Immunol 2000; 164: 3627.
27. WEST MJ, SLOMIANKA L, GUNDERSEN HJG. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat Rec 1991; 231: 482.
28. ANDERSSON PB, PERRY VH, GORDON S. The kinetics and morphological characteristics of the macrophage-microglial response to kainic acid-induced neuronal degeneration. Neuroscience 1991; 42: 201.
29. YI S, FENG X, HAWTHORNE W et al. CD8+ T cells are capable of rejecting pancreatic islet xenografts. Transplantation 2000; 70: 896.
30. WHITMIRE JK, SLIFKA MK, GREWAL IS, FLAVELL RA, AHMED R. CD40 ligand-deficient mice generate a normal primary cytotoxic T-lymphocyte response but a defective humoral response to a viral infection. J Virol 1996; 70: 8375.
31. LARSEN CP, ELWOOD ET, ALEXANDER DZ et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381: 434.
32. WOOD MJ, SLOAN DJ, WOOD KJ, CHARLTON HM. Indefinite survival of neural xenografts induced with anti-CD4 monoclonal antibodies. Neuroscience 1996; 70: 775.
33. WOOD MJA, SLOAN DJ, DALLMAN MJ, CHARLTON HM. Specific tolerance to neural allografts induced with an antibody to the interleukin 2 receptor. J Exp Med 1992; 117: 597.